We observed a distinct set of genetic alterations in the genomes of patients with HBsAg-positive DLBCL, which included frequent mutations in TET2, MYC, SPEN, SF3B1, ATM, EP300, and PTPN6. Here, MYC is linked to diffuse large B-cell lymphoma.